[1] BOCK J B, MATERN H T, PEDEN A A, et al. A genomic perspective on membrane compartment organization[J]. Nature, 2001,409(6822):839-841. [2] JAGER S, BUCCI C, TANIDA I, et al. Role for Rab7 in maturation of late autophagic vacuoles[J]. J Cell Sci, 2004,117(Pt 20):4837-4848. [3] BUCCI C, THOMSEN P, NICOZIANI P, et al. Rab7:a key to lysosome biogenesis[J]. Mol Biol Cell, 2000,11(2):467-480. [4] XIE JM, YAN Y, LIU F, et al. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells[J]. Biosci Rep, 2019,39(2):BSR20180480. [5] COGLI L, PROGIDA C, BRAMATO R, et al. Vimentin phosphorylation and assembly are regulated by the small GTPase Rab7a[J]. Biochim Biophys Acta, 2013,1833(6):1283-1293. [6] MARGIOTTA A, PROGIDA C, BAKKE O, et al. Rab7a regulates cell migration through Rac1 and vimentin[J]. Biochim Biophys Acta Mol Cell Res, 2017,1864(2):367-381. [7] KOU X, YANG Y, JIANG X, et al. Vorinostat and simvastatin have synergistic effects on triple-negative breast cancer cells via abrogating Rab7 prenylation[J]. Eur J Pharmacol, 2017,813:161-171. [8] CALVANO S E, XIAO W, RICHARDS D R, et al. A network-based analysis of systemic inflammation in humans[J]. Nature, 2005,437(7061):1032-1037. [9] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. [10] ZHENG Y, ZHANG M. Disparities of breast cancer burden between China and western countries and its implication[J]. Chin J Surg, 2015,53(12):905-909. [11] XU S, THOMPSON W, ANCOLI-ISRAEL S, et al. Cognition, quality-of-life, and symptom clusters in breast cancer:Using Bayesian networks to elucidate complex relationships[J]. Psychooncology, 2018,27(3):802-809. [12] HARBECK N, GNANT M. Breast cancer[J]. Lancet, 2017,389(10074):1134-1150. [13] WEIN L, LOI S. Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)[J]. Breast, 2017,34(Suppl 1):S27-S30. [14] JHAN J R, ANDRECHEK E R. Triple-negative breast cancer and the potential for targeted therapy[J]. Pharmacogenomics, 2017,18(17):1595-1609. [15] ZHAO T, DING X, YAN C, et al. Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice[J]. J Biol Chem, 2017,292(47):19198-19208. [16] WANG Q, LI H, ZHOU K, et al. Rab7 controls innate immunity by regulating phagocytosis and antimicrobial peptide expression in Chinese mitten crab[J]. Fish Shellfish Immunol, 2019,95:259-267. [17] MOHAPATRA G, GAUR P, MUJAGOND P, et al. A SUMOylation-dependent switch of RAB7 governs intracellular life and pathogenesis of Salmonella typhimurium[J]. J Cell Sci, 2019,132(1):jcs222612. [18] BARBIE T U, RITTER J L, ZHU Z, et al. Phosphorylation of RAB7 by TBK1/IKKepsilon regulates innate immune signaling in triple negative breast cancer[J]. Cancer Res, 2020,80(1):44-56. [19] NASR Z, ROBERT F, PORCO J A J R, et al. eIF4F suppression in breast cancer affects maintenance and progression[J]. Oncogene, 2013,32(7):861-871. [20] ADEM C, SODERBERG C L, HAFNER K, et al. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers[J]. Genes Chromosomes Cancer, 2004,41(1):1-11. |